International Private Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.62M Buy
14,379
+3,975
+38% +$855K 1.86% 17
2026
Q1
$2.26M Buy
10,404
+1,934
+23% +$429K 1.38% 18
2025
Q4
$1.94M Buy
8,470
+1,686
+25% +$384K 1.22% 20
2025
Q3
$1.57M Buy
6,784
+2,998
+79% +$611K 0.99% 27
2025
Q2
$703K Buy
3,786
+832
+28% +$155K 0.6% 36
2025
Q1
$619K Sell
2,954
-670
-18% -$130K 0.59% 40
2024
Q4
$644K Buy
+3,624
New +$666K 0.64% 37

Other funds holding ABBV

International Private Wealth Advisors's ABBV Position: Q2 2026 in Review

International Private Wealth Advisors increased its AbbVie (ABBV) stake by 38% in Q2 2026, buying an estimated $855K and bringing the position to 14,379 shares worth $3.62M. The position accounts for 1.86% of the portfolio, ranked #17.

International Private Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • International Private Wealth Advisors held 14,379 shares of AbbVie worth $3.62M as of Q2 2026.
  • International Private Wealth Advisors bought 3,975 AbbVie shares in Q2 2026, an estimated $855K.
  • AbbVie made up 1.86% of International Private Wealth Advisors's portfolio in Q2 2026, its #17 holding.
  • International Private Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on International Private Wealth Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.